Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Abdallah, Al-Ola  [Clear All Filters]
Journal Article
Hashmi H, Davis JA, Abdallah A-O. 'A Stitch in Time Saves Nine': Early stem cell transplant continues to improve outcomes in patients with newly diagnosed multiple myeloma. Expert Rev Hematol. 2023.
McGuirk M, Shahzad M, Amin MKashif, Khan MAtif, Bellman P, Mudaranthakam DPal, DeJarnette S, Lutfi F, Ahmed N, Bansal R, et al. Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience. Transpl Immunol. 2024:102039.
Mushtaq MUmair, Shahzad M, Amin MK, Lutfi F, DeJarnette S, Al-Ramahi JS, Li K, Ahmed N, Bansal R, Abdelhakim H, et al. Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation. Leuk Lymphoma. 2024:1-10.
Davis JA, Sborov DW, Wesson W, Julian K, Abdallah A-O, McGuirk JP, Ahmed N, Hashmi H. Efficacy and Safety of CD34+ Stem Cell Boost for Delayed Hematopoietic Recovery After BCMA Directed CAR T-cell Therapy. Transplant Cell Ther. 2023.
Gagelmann N, Dima D, Merz M, Hashmi H, Ahmed N, Tovar N, Oliver-Caldes A, Stölzel F, Rathje K, Fischer L, et al. Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma. J Clin Oncol. 2024:JCO2302232.
Hashmi H, Shebli A, Jain J, Khasawneh G, Mohan M, Mahmoudjafari Z, Cui W, McGuirk J, Shune L, Ahmed N, et al. Daratumumab, pomalidomide, and dexamethasone (DPd) followed by high dose chemotherapy-Autologous Stem Cell Transplantation leads to superior outcomes when compared to DPd-alone for patients with Relapsed Refractory Multiple Myeloma. Transplant Cell Ther. 2023.
Mohyuddin GRehman, Aziz M, McClune B, Abdallah A-O, Qazilbash M. Antibiotic Prophylaxis for Patients with Newly Diagnosed Multiple Myeloma: Systematic Review and Meta-Analysis. Eur J Haematol. 2019.